James L. Sherley

Dr. Sherley, MD, PhD, is head of Asymmetrex, a biotech start-up innovating adult stem cell technologies needed to achieve the promises of regenerative medicine.

[James L. Sherley @asymmetrex]

Recount the Vision: https://t.co/LPnzaGN5q2
Join the Next Future: https://t.co/Nb6MgfUoqq
Repost to share.

[James L. Sherley @asymmetrex]

HAVE YOU HEARD?!
ASYMMETREX® will soon introduce the SHERLOCK for accurate tissue stem cell counting and automated, precision cell line maintenance.
LEARN MORE and SIGN-UP to be notified when SHERLOCKs are ready for purchase in 2027: https://t.co/Nb6MgfUoqq
REPOST TO SHARE.

[James L. Sherley @asymmetrex]

Learn about the investment and share the info: https://t.co/Nb6MgfUoqq

[James L. Sherley @asymmetrex]

This week, Asymmetrex® is at ARMI BioFab|USA’s Meeting in the Millyard 2026 presenting the alpha-version of its new Sherlock instrument. Visit https://t.co/XC6dcde1Tj to see the first automated, differential tissue stem cell counter in action. https://t.co/pMznTNsPcl

[James L. Sherley @asymmetrex]

This week, Asymmetrex® is at ARMI BioFab|USA’s Meeting in the Millyard 2026 presenting the alpha-version of its new Sherlock instrument. Visit https://t.co/Nb6MgfUoqq to see the first automated, differential tissue stem cell counter in action.
Repost to share.

[James L. Sherley @asymmetrex]

Asymmetrex® is quite excited to share a big new development in our mission to improve cell research and accelerate progress in stem cell research! The SHERLOCK. Check it out and sign up to be among the first to use it: https://t.co/vh3iTdOX6m https://t.co/nA9Lywf2Ep

[James L. Sherley @asymmetrex]

Asymmetrex® is quite excited to share a big new development in our mission to improve cell research and accelerate progress in stem cell research! The SHERLOCK. Check it out and sign up to be among the first to use it: https://t.co/Nb6MgfUoqq

[James L. Sherley @asymmetrex]

NAM Stem Cells?
Register now to join Asymmetrex® Wed, May 6 to hear our pitch for partners to validate a new approach methodology (NAM) for early detection of tissue stem cell-toxic drugs.
https://t.co/ND2NR79dD0 https://t.co/ioDpztvWgT

[James L. Sherley @asymmetrex]

NAM Stem Cells?
Register now to join Asymmetrex® Wed, May 6 to hear our pitch for partners to validate a new approach methodology (NAM) for early detection of tissue stem cell-toxic drugs.
https://t.co/m3xA7VsnNs

[James L. Sherley @asymmetrex]

Asymmetrex at COG-NE 2026, April 28, presenting on the importance of cell standards for recently accelerated 3Rs (replacement, refinement, reduction) efforts to reduce the use of animals in testing and research.
https://t.co/xxZQrNlpmx
Repost to share.

[James L. Sherley @asymmetrex]

Asymmetrex at COG-NE 2026, April 28, presenting on the importance of cell standards for recently accelerated 3Rs (replacement, refinement, reduction) efforts to reduce the use of animals in testing and reserch.
https://t.co/vUhilA0sEB https://t.co/tojeYGK03g

[James L. Sherley @asymmetrex]

A new Drug Discovery World perspective highlights recent discoveries made using Asymmetrex®'s differential stem cell counting technology. https://t.co/ZgbYBTR7PJ https://t.co/jFBJmu617q

[James L. Sherley @asymmetrex]

Check out the new paper here: https://t.co/l97VfEqhPK
Repost to share.
https://t.co/l3JZ0fXPRH

[James L. Sherley @asymmetrex]

Check out the new paper here: https://t.co/6DF3R4KsIb
Repost to share.

[James L. Sherley @asymmetrex]

FDA recognizes method for cell proliferation rate measurement as a Voluntary Consensus Standard for regenerative medicine. Learn how Asymmetrex® joined in informing this important new designation: https://t.co/EI6mIEoebn https://t.co/nmPI4maDdl

[James L. Sherley @asymmetrex]

FDA CBER recognizes method for cell proliferation rate measurement as a Voluntary Consensus Standard (VCS) for accelerating advances in regenerative medicine. Learn how Asymmetrex® joined in informing this important new designation: https://t.co/oCFA81tmYU
Repost to share.

[James L. Sherley @asymmetrex]

In this season of light and hope, an appreciation from Asymmetrex® https://t.co/eKBoP4r4oS

[James L. Sherley @asymmetrex]

Asymmetrex® had a great time at #CellBio2025 introducing the new cell monitor-counter it is developing for cell research. Sample what the new instrument will do at: https://t.co/K5NsT1SiAt
Repost to share.

[James L. Sherley @asymmetrex]

Quite nostalgic for Asymmetrex®’s booth at #CellBio2025 to be so near #ASCB’s journal #MBoC! A foundational paper for Asymmetrex’s technologies for stem cell medicine was published in #MBoC. Join us in connecting to our origins at: https://t.co/NDm35bBluN
Repost to share.